Speakers

50+ Leading CAR-TCR Drug Developers Confirmed to Present:

Blake Aftab

Chief Scientific Officer

Adicet Bio

Cécile Bauche

Chief Executive Officer & Chief Scientific Officer

Alaya.bio

Reagan Jarvis

Chief Executive Officer

Anocca

Sara Padrell

Business Development Director

Akron Bio

Flavio Lima Bianchi

Adoptive Cell Analyst

Beacon Targeted Therapies

Jakob Dupont

Executive Vice President, Head of Global Research & Development

Atara Biotherapeutics

Nick Haining

Co-Founder & Chief Scientific Officer

Arsenal Bio

Sven Killi

Chief Executive Officer

Antion Biosciences SA

Adrian Bot, MD, PhD

Chief Scientific Officer and Executive Vice President, R&D

Capstan Therapeutics

Ann Ager

Professor, Cellular Immunity & Immunotherapy

Cardiff University

Jiangtao Ren

Co-Founder & Chief Scientific Officer

Bioheng Biotech

Samik Basu

Chief Scientific Officer

Cabaletta Bio

Andy Stewart

Senior Director, Research

Cartesian Therapeutics

Daniel Teper

Chief Executive Officer

Cytovia Therapeutics

Jamal El-Mosleh

Chief Executive Officer

Elicera Therapeutics

Laurent Poirot

Senior Vice President, Immunology

Cellectis

Alan Baer

Staff Fellow, Division of Cellular & Gene Therapies, CBER

FDA

Joseph Dukes

Head of Research

Enara Bio

Kevin Pojasek

President & Chief Executive Officer

Enara Bio

Sophie Papa

Chief Medical Officer

Enara Bio

Andrea Mayer-Mokler

Senior Director, Global Head Clinical Sciences

Immatics

Cedrik Britten

Chief Medical Officer

Immatics

Mamta Kalra

Senior Director, CMC

Immatics

Manel Juan

Head of Immunology Service

Hospital Clinic of Barcelona

Bakul Gupta

Co-Founder & Chief Executive Officer

ImmTune Therapies

Lawrence Lamb

Chief Scientific Officer

IN8bio

Rohan Kamat

Head of Process & Analytical Development

Immuneel Therapeutics

Sarbari Ghosh

Scientist, Process & Analytical Development

Immuneel Therapeutics

Frederik De Vos

Senior Director, CAR-T Quality

Johnson & Johnson

Hemant Dhamne

Head of Process Development, Gene Therapy Vector Facility

King’s College London

Reuben Benjamin

Consultant Haematologist & Honorary Clinical Senior Lecturer

King’s College London

Rhine Shen

Senior Director, Head of Clinical Pharmacology

Kite Pharma: A Gilead Company

Gary Lee

Chief Scientific Officer

Lyell Immunopharma

John Maher

Chief Scientific Officer

Leucid Bio

Simona Guidi

Senior Consultant

ProPharma Group

Vaishali Shukla

Vice President, Quality, Commercial Manufacturing

Kite Pharma: A Gilead Company

Amir Hefni

Vice President & Global Head, Cell & Gene Therapy

Novartis

Houra Loghmani

Senior Scientist, Translational Oncology

Oncolytics Biotech

Miriam Fuchs

Executive Director, Global Therapeutic Area Lead, Regulatory Affairs, Cell & Gene Therapy

Novartis

Özlem Anak

Vice President, Global Programme Head, Cell & Gene

Novartis

Aaron Foster

Vice President, Immunology

Sana Biotechnology

Dan Shelly

Vice President, Business Development & Alliances

Prescient Therapeutics

David DiLillo

Director, Immuno-Oncology

Regeneron Pharmaceuticals

Vered Caplan

Chief Executive Officer

Orgenesis

Bryan Kobel

Chief Executive Officer

TC BioPharm

Emily Kuiper

Senior Scientist

SOTIO Biotech

Mindy Miller

Lead Research Scientist, R&D

Terumo Blood & Cell Technologies

Thomas Andresen

Chief Executive Officer

T-Cyhper Bio

Deyaa Adib

Chief Medical Officer

Triumvira Immunologics

James Keck

Senior Director, Innovation & Product Development

The Jackson Laboratory

Mikhail Steklov

Next-Gen Technologies Manager

T-Knife Therapeutics

Renu Balyan

Manager, Diagnostics & Biomarker Lead, Clinical Development

Tessa Therapeutics

Aaron K. Sato, Ph.D.

Chief Scientific Officer

Twist Bioscience

Kenneth Jacobs

Vice President, Pharmacovigilance & Clinical Development

Wugen

Luise Weigand

Head of Research

Zelluna Immunotherapy

Qasim Rafiq

Senior Lecturer & Associate Professor - Cell & Gene Therapy Bioprocessing

University College London

Anthony (AJ) Messina

Director, Assessment & Insight, Insights Gathering

Syneos Health